Active ingredient obtained from calendula officinalis and use in the prevention and treatment of cutaneous manifestations due to an imbalance in the epigenome in skin cells
The use of an active ingredient obtained from Calendula officinalis flowers as a product with topical application on the skin in the prevention or treatment of cutaneous manifestations caused by an imbalance of the epigenome in skin cells. Also, a hydrolyzate of Calendula officinalis flowers including oligosaccharides with a degree of polymerization of between 2 and 10, of fructose and glucose, with the compositions including it, and a cosmetic skin-care process.
